Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

FUREGRELATE

SKU: orb1309655

Description

FUREGRELATE is a selective thromboxane A2 synthase inhibitor used in research. It has been shown to attenuate the progression of pulmonary arterial hypertension in neonatal piglet models. This small molecule is a valuable tool for studying the role of TxA2 in cardiovascular and pulmonary diseases in both in vivo and in vitro experimental systems.

Research Area

Immunology & Inflammation, Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number85666-24-6
MW253.25
Purity99.71% (May vary between batches)
FormulaC15H11NO3
SMILESC(O)(=O)C1=CC=2C(O1)=CC=C(CC=3C=CC=NC3)C2
TargetProstaglandin Receptor,Others,PPAR
SolubilityDMSO:50 mg/mL (197.43 mM)

Bioactivity

In Vitro
A third group of piglets received FUREGRELATE (3 mg/kg, 2 or 3 times daily) at the induction of CH. In vivo hemodynamics confirmed a 2.55-fold increase of the pulmonary vascular resistance index (PVRI) in CH piglets (104±7 WU) compared to N piglets (40±2 WU). The CH piglets treated twice daily with FUREGRELATE failed to show improved PVRI, but FUREGRELATE three times daily lowered the elevated PVRI in CH piglets by 34% to 69±5 WU and ameliorated the development of right ventricular hypertrophy. Microfocal X-ray computed tomography (CT) scanning was used to estimate the diameter-independent distensibility term, α (% change in diameter per Torr). Pulmonary arterial distensibility in isolated lungs of CH piglets (α=1.0±0.1% per Torr) was lower than that of N piglets (α=1.5±0.1% per Torr) indicative of vascular remodeling. Arterial distensibility was partially restored in FUREGRELATE-treated CH piglets (α =1.2±0.1% per Torr) and microscopic evidence showing muscularization of small pulmonary arteries also was less prominent in these animals. Finally, isolated lungs of FUREGRELATE-treated piglets showed lower basal and vasodilator-induced transpulmonary pressures compared to CH animals.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

FUREGRELATE, Furegrelate, TXA2R

Similar Products

  • Furegrelate sodium [orb1309656]

    99.92% (May vary between batches)

    85666-17-7

    275.23

    C15H10NNaO3

    5 mg, 500 mg, 1 ml x 10 mM (in DMSO), 10 mg, 25 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 160.00
1 ml x 10 mM (in DMSO)
$ 280.00
5 mg
$ 310.00
10 mg
$ 430.00
25 mg
$ 640.00
50 mg
$ 870.00
100 mg
$ 1,150.00
200 mg
$ 1,520.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry